Arcana Institute (INAR) is now part of Certara, a global leader in model-informed drug development and regulatory science.

Arcana Institute, together with Analytica Laser and other companies acquired by Certara, provides support for drug development through the product’s full life cycle, from clinical trial planning & design, drug registration, Real World Data, strategic support in HEOR and Market Access, up to reimbursement and beyond.

Certara’s staff includes over 700 experts in more than 20 offices worldwide!

Together, we are creating innovative analytical methods to provide our partners with the highest-quality scientific evidence in safety, clinical efficacy and effectiveness for medical technologies.

find out more

Business Partners

Cooperative Institutions


7 September 2018

Analysis of the Reimbursement Decision-Making Practice in Poland (September 2018)

The latest results of the periodic Analysis of the Reimbursement Decision-Making Practice of AHTAPol and the Minister of Health The results include the notice of the Minister of Health from 29 August  more...
27 July 2018

Innovations in healthcare. VI HTA Symposium

Session Summary from VI HTA Symposium (11-12 June 2018) DAY I, SESSION 3: Innovations in healthcare The panellists: Aleksandra Mościcka-Studzińska, Ewa Kalinka-Warzocha, Grzegorz Mączyński, Adam  more...
26 July 2018

A modern hospital: telemedicine, hospital network, central purchases in Poland

Session Summary from VI HTA Symposium (11-12 June 2018) DAY II, SESSION I: A modern hospital The panellists: Wojciech Szefke, Paweł Grzesiowski, Agnieszka Pachciarz, Waldemar Stylo, Krzysztof Łanda,  more...